Phase 4
N=1,044
Polyethylene Glycol Versus Low Volume Solutions Prior to Colonoscopy
Colonoscopy
Bottom Line
View on ClinicalTrials.gov: NCT02956057 ↗Enrolled (actual)
1,044
Serious AEs
—
Results posted
Oct 2020
Primary outcome: Primary: Quality of Bowel Preparation Using the Aronchick Scale ( Score 1+2) — 110; 145; 100; 134 Participants
Study Design & Population
- Study type
- Interventional
- Phase
- Phase 4
- Interventions
- Polyethylene Glycols (Drug); Natrium picosulfate / Magnesium citrate (Drug); Polyethylene glycol / Ascorbic acid (Drug)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Tomas Bata Hospital, Czech Republic
- Primary completion
- May 2017
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Quality of Bowel Preparation Using the Aronchick Scale ( Score 1+2) |
110; 145; 100; 134; 121; 55 | — |
| SECONDARY Tolerance of Bowel Preparation Assessed by 5 Point VAS ( Score 1+2) |
56; 72; 134; 139; 85; 80 | — |
Summary
Study evaluates the efficacy and tolerability of low volume preparations compared with conventional 4L polyethylene glycol prior to colonoscopy
Eligibility Criteria
Inclusion Criteria
- Subjects referred to diagnostic or therapeutic colonoscopy
Exclusion Criteria
- ileus
- known or suspected bowel obstruction
- active bowel inflammation
- pregnancy
- any presence of serious medical conditions
- history of prior colonic or rectal surgery
- inability to obtain valid data from subject
Data sourced from ClinicalTrials.gov (NCT02956057). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.